Use of NADH and NADPH for the manufacture of a medicament for the treatment of Alzheimer's disease

Use of the reduced form of nicotinamide adenine dinucleotide (NADH), of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or of a physiologically tolerated salt thereof for producing a medicine/medicament for the treatment of Alzheimer's disease.

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	BIRKMAYER, JOERG, UNIV
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Use of the reduced form of nicotinamide adenine dinucleotide (NADH), of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or of a physiologically tolerated salt thereof for producing a medicine/medicament for the treatment of Alzheimer's disease.